Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
McKesson
Express Scripts
Medtronic

Last Updated: January 19, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BETAXOLOL HYDROCHLORIDE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for betaxolol hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000132 Early Manifest Glaucoma Trial (EMGT) Unknown status National Eye Institute (NEI) Phase 3 1992-10-01 The primary purpose is to compare the effect of immediate therapy to lower the intraocular pressure (IOP) versus late or no treatment on the progression of newly detected open-angle glaucoma, as measured by increasing visual field loss and/or optic disc changes. The secondary purposes are to determine the extent of IOP reduction attained by treatment, to explore factors that may influence glaucoma progression, and to describe the natural history of newly detected glaucoma.
NCT01660620 Topical Betaxolol for the Prevention of Retinopathy of Prematurity Completed Ohio State University Phase 1 2011-04-01 We hypothesize that topical betaxolol will reduce the development of severe retinopathy of prematurity.
NCT01660620 Topical Betaxolol for the Prevention of Retinopathy of Prematurity Completed The University of Texas Health Science Center, Houston Phase 1 2011-04-01 We hypothesize that topical betaxolol will reduce the development of severe retinopathy of prematurity.
NCT01660620 Topical Betaxolol for the Prevention of Retinopathy of Prematurity Completed University of Minnesota - Clinical and Translational Science Institute Phase 1 2011-04-01 We hypothesize that topical betaxolol will reduce the development of severe retinopathy of prematurity.
NCT01660620 Topical Betaxolol for the Prevention of Retinopathy of Prematurity Completed University of Oklahoma Phase 1 2011-04-01 We hypothesize that topical betaxolol will reduce the development of severe retinopathy of prematurity.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for betaxolol hydrochloride

Condition Name

Condition Name for betaxolol hydrochloride
Intervention Trials
Development of Side Effects From Betaxolol 1
Open-Angle Glaucoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for betaxolol hydrochloride
Intervention Trials
Glaucoma 1
Retinopathy of Prematurity 1
Retinal Diseases 1
Premature Birth 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for betaxolol hydrochloride

Trials by Country

Trials by Country for betaxolol hydrochloride
Location Trials
Sweden 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for betaxolol hydrochloride

Clinical Trial Phase

Clinical Trial Phase for betaxolol hydrochloride
Clinical Trial Phase Trials
Phase 3 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for betaxolol hydrochloride
Clinical Trial Phase Trials
Completed 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for betaxolol hydrochloride

Sponsor Name

Sponsor Name for betaxolol hydrochloride
Sponsor Trials
National Eye Institute (NEI) 1
Smith-Kettlewell Eye Research Institute 1
University of Oklahoma 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for betaxolol hydrochloride
Sponsor Trials
Other 5
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Moodys
Express Scripts
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.